Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors

被引：15

作者：

Aldea, Mihaela ^{[1
,2
]}

Tagliamento, Marco ^{[1
,3
]}

Bayle, Arnaud ^{[2
,4
]}

Vasseur, Damien ^{[5
]}

Verge, Veronique ^{[5
]}

Marinello, Arianna ^{[1
]}

Danlos, Francois-Xavier ^{[2
,4
]}

Blanc-Durand, Felix ^{[1
]}

Bernard, Elsa ^{[6
]}

Cerbone, Luigi ^{[1
]}

Mosele, Maria Fernanda ^{[1
]}

Renneville, Aline ^{[5
]}

Hadoux, Julien ^{[1
]}

Loriot, Yohann ^{[1
,4
]}

Sakkal, Madona ^{[1
,4
]}

Vozy, Aurore ^{[1
]}

Sarkozy, Clementine ^{[6
]}

Smolenschi, Cristina ^{[1
,4
]}

Nicotra, Claudio ^{[4
]}

Martin-Romano, Patricia ^{[4
]}

Boccon-Gibod, Clementine ^{[6
]}

Habza, Wafikaamira ^{[6
]}

Lazarovici, Julien ^{[6
]}

Ponce, Santiago ^{[4
]}

Hollebecque, Antoine ^{[4
]}

Marzac, Christophe ^{[4
,6
]}

Lacroix, Ludovic ^{[5
]}

Barlesi, Fabrice ^{[1
,7
]}

Andre, Fabrice ^{[1
,2
]}

Besse, Benjamin ^{[1
,2
]}

Rouleau, Etienne ^{[5
]}

Italiano, Antoine ^{[1
,7
]}

Micol, Jean-Baptiste ^{[2
,6
]}

机构：

[1] Gustave Roussy, Dept Med, Villejuif, France

[2] Univ Paris Saclay, Paris, France

[3] Univ Genoa, Dept Internal Med & Med Specialties, DIMi, Genoa, Italy

[4] Gustave Roussy, Drug Dev Dept, Villejuif, France

[5] Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France

[6] Univ Paris Saclay, Intercept Program, Personalized Canc Prevent Ctr, Gustave Roussy, Villejuif, France

[7] Aix Marseille Univ, CNRS, INSERM, CRCM, Marseille, France

来源：

JCO PRECISION ONCOLOGY | 2023年 / 7卷

关键词：

CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; COMMON; BLOOD; TET2;

D O I：

10.1200/PO.22.00583

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PURPOSEHigh-risk clonal hematopoiesis (CH) is frequently incidentally found in patients with solid tumors undergoing plasma cell-free DNA sequencing. Here, we aimed to determine if the incidental detection of high-risk CH by liquid biopsy may reveal occult hematologic malignancies in patients with solid tumors.MATERIALS AND METHODSAdult patients with advanced solid cancers enrolled in the Gustave Roussy Cancer Profiling study (ClinicalTrials.gov identifier: NCT04932525) underwent at least one liquid biopsy (FoundationOne Liquid CDx). Molecular reports were discussed within the Gustave Roussy Molecular Tumor Board (MTB). Potential CH alterations were observed, and patients referred to hematology consultation in the case of pathogenic mutations in JAK2, MPL, or MYD88, irrespective of the variant allele frequency (VAF), or in DNMT3A, TET2, ASXL1, IDH1, IDH2, SF3B1, or U2AF1 with VAF >= 10%, while also considering patient cancer-related prognosis. TP53 mutations were discussed case-by-case.RESULTSBetween March and October 2021, 1,416 patients were included. One hundred ten patients (7.7%) carried at least one high-risk CH mutation: DNMT3A (n = 32), JAK2 (n = 28), TET2 (n = 19), ASXL1 (n = 18), SF3B1 (n = 5), IDH1 (n = 4), IDH2 (n = 3), MPL (n = 3), and U2AF1 (n = 2). The MTB advised for hematologic consultation in 45 patients. Overall, 9 patients of 18 actually addressed had confirmed hematologic malignancies that were occult in six patients: two patients had myelodysplastic syndrome, two essential thrombocythemia, one a marginal lymphoma, and one a Waldenstrom macroglobulinemia. The other three patients were already followed up in hematology.CONCLUSIONThe incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.

引用

页数：14

共 24 条

[1] Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients [J].

Aldea, M. ;

Cerbone, L. ;

Bayle, A. ;

Parisi, C. ;

Sarkozy, C. ;

Vasseur, D. ;

Verlingue, L. ;

Blanc-Durand, F. ;

Mosele, F. ;

Sakkal, M. ;

Ponce, S. ;

Lavaud, P. ;

Loriot, Y. ;

Hollebecque, A. ;

Massard, C. ;

Soria, J. -c. ;

Lacroix, L. ;

Rouleau, E. ;

Italiano, A. .

ANNALS OF ONCOLOGY, 2021, 32 (12) :1642-1645

[2] International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert P. ;

Borowitz, Michael J. ;

Calvo, Katherine R. ;

Kvasnicka, Hans-Michael ;

Wang, Sa A. ;

Bagg, Adam ;

Barbui, Tiziano ;

Branford, Susan ;

Bueso-Ramos, Carlos E. ;

Cortes, Jorge E. ;

Dal Cin, Paola ;

DiNardo, Courtney D. ;

Dombret, Herve ;

Duncavage, Eric J. ;

Ebert, Benjamin L. ;

Estey, Elihu H. ;

Facchetti, Fabio ;

Foucar, Kathryn ;

Gangat, Naseema ;

Gianelli, Umberto ;

Godley, Lucy A. ;

Gokbuget, Nicola ;

Gotlib, Jason ;

Hellstrom-Lindberg, Eva ;

Hobbs, Gabriela S. ;

Hoffman, Ronald ;

Jabbour, Elias J. ;

Kiladjian, Jean-Jacques ;

Larson, Richard A. ;

Le Beau, Michelle M. ;

Loh, Mignon L. -C. ;

Lowenberg, Bob ;

Macintyre, Elizabeth ;

Malcovati, Luca ;

Mullighan, Charles G. ;

Niemeyer, Charlotte ;

Odenike, Olatoyosi M. ;

Ogawa, Seishi ;

Orfao, Alberto ;

Papaemmanuil, Elli ;

Passamonti, Francesco ;

Porkka, Kimmo ;

Pui, Ching-Hon ;

Radich, Jerald P. ;

Reiter, Andreas ;

Rozman, Maria ;

Rudelius, Martina ;

Savona, Michael R. .

BLOOD, 2022, 140 (11) :1200-1228

[3] Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma [J].

Asmar, Fazila ;

Punj, Vasu ;

Christensen, Jesper ;

Pedersen, Marianne T. ;

Pedersen, Anja ;

Nielsen, Anders B. ;

Hother, Christoffer ;

Ralfkiaer, Ulrik ;

Brown, Peter ;

Ralfkiaer, Elisabeth ;

Helin, Kristian ;

Grenbaek, Kirsten .

HAEMATOLOGICA, 2013, 98 (12) :1912-1920

[4] Cancer therapy shapes the fitness landscape of clonal hematopoiesis [J].

Bolton, Kelly L. ;

Ptashkin, Ryan N. ;

Gao, Teng ;

Braunstein, Lior ;

Devlin, Sean M. ;

Kelly, Daniel ;

Patel, Minal ;

Berthon, Antonin ;

Syed, Aijazuddin ;

Yabe, Mariko ;

Coombs, Catherine C. ;

Caltabellotta, Nicole M. ;

Walsh, Mike ;

Offit, Kenneth ;

Stadler, Zsofia ;

Mandelker, Diana ;

Schulman, Jessica ;

Patel, Akshar ;

Philip, John ;

Bernard, Elsa ;

Gundem, Gunes ;

Ossa, Juan E. Arango ;

Levine, Max ;

Martinez, Juan S. Medina ;

Farnoud, Noushin ;

Glodzik, Dominik ;

Li, Sonya ;

Robson, Mark E. ;

Lee, Choonsik ;

Pharoah, Paul D. P. ;

Stopsack, Konrad H. ;

Spitzer, Barbara ;

Mantha, Simon ;

Fagin, James ;

Boucai, Laura ;

Gibson, Christopher J. ;

Ebert, Benjamin L. ;

Young, Andrew L. ;

Druley, Todd ;

Takahashi, Koichi ;

Gillis, Nancy ;

Ball, Markus ;

Padron, Eric ;

Hyman, David M. ;

Baselga, Jose ;

Norton, Larry ;

Gardos, Stuart ;

Klimek, Virginia M. ;

Scher, Howard ;

Bajorin, Dean .

NATURE GENETICS, 2020, 52 (11) :1219-+

[5] IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma [J].

Cairns, Rob A. ;

Iqbal, Javeed ;

Lemonnier, Francois ;

Kucuk, Can ;

de Leval, Laurence ;

Jais, Jean-Philippe ;

Parrens, Marie ;

Martin, Antoine ;

Xerri, Luc ;

Brousset, Pierre ;

Chan, Li Chong ;

Chan, Wing-Chung ;

Gaulard, Philippe ;

Mak, Tak W. .

BLOOD, 2012, 119 (08) :1901-1903

[6] Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes [J].

Coombs, Catherine C. ;

Zehir, Ahmet ;

Devlin, Sean M. ;

Kishtagari, Ashwin ;

Syed, Aijazuddin ;

Jonsson, Philip ;

Hyman, David M. ;

Solit, David B. ;

Robson, Mark E. ;

Baselga, Jose ;

Arcila, Maria E. ;

Ladanyi, Marc ;

Tallman, Martin S. ;

Levine, Ross L. ;

Berger, Michael F. .

CELL STEM CELL, 2017, 21 (03) :374-+

[7] TET2 and DNMT3A Mutations in Human T-Cell Lymphoma [J].

Couronne, Lucile ;

Bastard, Christian ;

Bernard, Olivier A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01) :95-96

[8] Somatic mutations precede myeloid leukemia years before diagnosis [J].

Desai, Pinkal ;

Mencia-Trinchant, Nuria ;

Savenkov, Oleksandr ;

Simon, Michael S. ;

Cheang, Gloria ;

Lee, Sangmin ;

Samuel, Michael ;

Ritchie, Ellen K. ;

Guzman, Monica L. ;

Ballman, Karla V. ;

Roboz, Gail J. ;

Hassane, Duane C. .

NATURE MEDICINE, 2018, 24 (07) :1015-+

[9] Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence [J].

Genovese, Giulio ;

Kaehler, Anna K. ;

Handsaker, Robert E. ;

Lindberg, Johan ;

Rose, Samuel A. ;

Bakhoum, Samuel F. ;

Chambert, Kimberly ;

Mick, Eran ;

Neale, Benjamin M. ;

Fromer, Menachem ;

Purcell, Shaun M. ;

Svantesson, Oscar ;

Landen, Mikael ;

Hoeglund, Martin ;

Lehmann, Soeren ;

Gabriel, Stacey B. ;

Moran, Jennifer L. ;

Lander, Eric S. ;

Sullivan, Patrick F. ;

Sklar, Pamela ;

Groenberg, Henrik ;

Hultman, Christina M. ;

McCarroll, Steven A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (26) :2477-2487

[10] Clonal hematopoiesis in human aging and disease [J].

Jaiswal, Siddhartha ;

Ebert, Benjamin L. .

SCIENCE, 2019, 366 (6465) :586-+

← 1 2 3 →